ArticleAntimicrobial agents and chemotherapy2005

TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro.

Cécile L Tremblay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.